REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Zhengye Biotechnology Holding Ltd. (正业生物科技控股有限公司) (China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Zhengye Biotechnology Holding Ltd. Profile Updated: July 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

The Company through its consolidated subsidiaries principally focused on the research, development, manufacture and sales of veterinary vaccines. The Company was established in 2023 and is headquartered in Jilin City, Jilin Province.

Headquarters
3-212 Governors Square, 23 Lime Tree Bay Avenue
George Town; Grand Cayman;

Contact Details: Purchase the Zhengye Biotechnology Holding Ltd. (正业生物科技控股有限公司) report to view the information.

Website: http://www.jlzybio.com

Basic Information
Total Employees:
Purchase the Zhengye Biotechnology Holding Ltd. (正业生物科技控股有限公司) report to view the information.
Outstanding Shares:
Purchase the Zhengye Biotechnology Holding Ltd. (正业生物科技控股有限公司) report to view the information.
Financial Auditors:
Purchase the Zhengye Biotechnology Holding Ltd. (正业生物科技控股有限公司) report to view the information.
Incorporation Date:
December 09, 2025
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Chief Operating Officer
Purchase this report to view the information.
Vice Managing Director
Ownership Details
Purchase this report to view the information.
84.81%
Purchase this report to view the information.
0.26%
Purchase this report to view the information.
0.18%
Purchase this report to view the information.
0.11%
Purchase this report to view the information.
Subsidiaries
Vvax Skyline Holdings Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Zhengye Biotechnology Holding Ltd. (正业生物科技控股有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-11.95%▼
Total operating revenue
-11.11%▼
Operating profit (EBIT)
-60.31%▼
EBITDA
-46.03%▼
Net Profit (Loss) for the Period
-64.09%▼
Total assets
-1.33%▼
Total equity
3.91%▲
Operating Profit Margin (ROS)
-11.46%▼
Net Profit Margin
-10.49%▼
Return on Equity (ROE)
-7.24%▼
Debt to Equity Ratio
-1.96%▼
Quick Ratio
-0.1%▼
Cash Ratio
0.04%▲

Similar companies

Sinopharm Group Company Limited
 
JD Health International Inc.
Zhejiang Nhu Company Ltd.
 
YSB Inc.
China Medical System Holdings Limited
 
Xilong Scientific Co.,Ltd
Raily Aesthetic Medicine International Holdings Limited (Hangzhou) (瑞丽医美国际控股有限公司 (杭州))
 
BGM Group Ltd.
Universe Pharmaceuticals Inc.
 
CANbridge Pharmaceuticals Inc. (Hong Kong) (北海康成制药有限公司 (香港))
Immuneonco Biopharmaceuticals (Shanghai) Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo